Effectiveness and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma in a Real-Life Population in France: The Remix Study
Gespeichert in:
Veröffentlicht in: | Blood 2022-11, Vol.140 (Supplement 1), p.4312-4314 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4314 |
---|---|
container_issue | Supplement 1 |
container_start_page | 4312 |
container_title | Blood |
container_volume | 140 |
creator | Vincent, Laure Charvet-Rumpler, Anne Benboubker, Lotfi Calmettes, Claire Stoppa, Anne-Marie Laribi, Kamel Clement Filliatre, Lauriane Honeyman, Fressia Valentine, Richez Hulin, Cyrille Maloisel, Frédéric Macro, Margaret Karlin, Lionel Barué, Vanessa Chouaid, Christos Zerazhi, Hacène Leleu, Xavier |
description | |
doi_str_mv | 10.1182/blood-2022-157942 |
format | Article |
fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_157942</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122034309</els_id><sourcerecordid>S0006497122034309</sourcerecordid><originalsourceid>FETCH-LOGICAL-c942-5a214eeee9c626c9d5b5dc53b052eecde0011ff9f5c8743d59da0fad9ba6fff23</originalsourceid><addsrcrecordid>eNp9kMFOAjEQhhujiYg-gLe-wGpbtsDqyaAoCUQj3Dez7TTUdLekXZT1xXw9C3i2lzaZ_-vMfIRcc3bD-VjcVs57nQkmRMblqMjFCelxKcYZY4Kdkh5jbJjlxYifk4sYPxjj-UDIHvl5MgZVaz-xwRgpNJouwWDbUW_obAffvrYVtQ2d-LqyDbTWN_TLtms6xwac1amu8cA94g5qbNcQfYN75B0dbCJq6kN6mwCq9aGji61r7cYhXXTofA37KKQAuGxuDdI3v9m6Y6NUmQZoFN7R1RpTprY7umy3urskZwZcxKu_u09W06fV5CWbvz7PJg_zTCUHmQTBc0ynUEMxVIWWldRKDiomBaLSmDxwYwoj1XiUD7QsNDADuqhgaIwRgz7hx29V8DEGNOUm2BpCV3JW7sWXB_HlXnx5FJ-Y-yODaa5Pi6GMymJaQtuQVJfa23_oX65GkHY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effectiveness and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma in a Real-Life Population in France: The Remix Study</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Vincent, Laure ; Charvet-Rumpler, Anne ; Benboubker, Lotfi ; Calmettes, Claire ; Stoppa, Anne-Marie ; Laribi, Kamel ; Clement Filliatre, Lauriane ; Honeyman, Fressia ; Valentine, Richez ; Hulin, Cyrille ; Maloisel, Frédéric ; Macro, Margaret ; Karlin, Lionel ; Barué, Vanessa ; Chouaid, Christos ; Zerazhi, Hacène ; Leleu, Xavier</creator><creatorcontrib>Vincent, Laure ; Charvet-Rumpler, Anne ; Benboubker, Lotfi ; Calmettes, Claire ; Stoppa, Anne-Marie ; Laribi, Kamel ; Clement Filliatre, Lauriane ; Honeyman, Fressia ; Valentine, Richez ; Hulin, Cyrille ; Maloisel, Frédéric ; Macro, Margaret ; Karlin, Lionel ; Barué, Vanessa ; Chouaid, Christos ; Zerazhi, Hacène ; Leleu, Xavier</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-157942</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.4312-4314</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids></links><search><creatorcontrib>Vincent, Laure</creatorcontrib><creatorcontrib>Charvet-Rumpler, Anne</creatorcontrib><creatorcontrib>Benboubker, Lotfi</creatorcontrib><creatorcontrib>Calmettes, Claire</creatorcontrib><creatorcontrib>Stoppa, Anne-Marie</creatorcontrib><creatorcontrib>Laribi, Kamel</creatorcontrib><creatorcontrib>Clement Filliatre, Lauriane</creatorcontrib><creatorcontrib>Honeyman, Fressia</creatorcontrib><creatorcontrib>Valentine, Richez</creatorcontrib><creatorcontrib>Hulin, Cyrille</creatorcontrib><creatorcontrib>Maloisel, Frédéric</creatorcontrib><creatorcontrib>Macro, Margaret</creatorcontrib><creatorcontrib>Karlin, Lionel</creatorcontrib><creatorcontrib>Barué, Vanessa</creatorcontrib><creatorcontrib>Chouaid, Christos</creatorcontrib><creatorcontrib>Zerazhi, Hacène</creatorcontrib><creatorcontrib>Leleu, Xavier</creatorcontrib><title>Effectiveness and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma in a Real-Life Population in France: The Remix Study</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kMFOAjEQhhujiYg-gLe-wGpbtsDqyaAoCUQj3Dez7TTUdLekXZT1xXw9C3i2lzaZ_-vMfIRcc3bD-VjcVs57nQkmRMblqMjFCelxKcYZY4Kdkh5jbJjlxYifk4sYPxjj-UDIHvl5MgZVaz-xwRgpNJouwWDbUW_obAffvrYVtQ2d-LqyDbTWN_TLtms6xwac1amu8cA94g5qbNcQfYN75B0dbCJq6kN6mwCq9aGji61r7cYhXXTofA37KKQAuGxuDdI3v9m6Y6NUmQZoFN7R1RpTprY7umy3urskZwZcxKu_u09W06fV5CWbvz7PJg_zTCUHmQTBc0ynUEMxVIWWldRKDiomBaLSmDxwYwoj1XiUD7QsNDADuqhgaIwRgz7hx29V8DEGNOUm2BpCV3JW7sWXB_HlXnx5FJ-Y-yODaa5Pi6GMymJaQtuQVJfa23_oX65GkHY</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Vincent, Laure</creator><creator>Charvet-Rumpler, Anne</creator><creator>Benboubker, Lotfi</creator><creator>Calmettes, Claire</creator><creator>Stoppa, Anne-Marie</creator><creator>Laribi, Kamel</creator><creator>Clement Filliatre, Lauriane</creator><creator>Honeyman, Fressia</creator><creator>Valentine, Richez</creator><creator>Hulin, Cyrille</creator><creator>Maloisel, Frédéric</creator><creator>Macro, Margaret</creator><creator>Karlin, Lionel</creator><creator>Barué, Vanessa</creator><creator>Chouaid, Christos</creator><creator>Zerazhi, Hacène</creator><creator>Leleu, Xavier</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Effectiveness and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma in a Real-Life Population in France: The Remix Study</title><author>Vincent, Laure ; Charvet-Rumpler, Anne ; Benboubker, Lotfi ; Calmettes, Claire ; Stoppa, Anne-Marie ; Laribi, Kamel ; Clement Filliatre, Lauriane ; Honeyman, Fressia ; Valentine, Richez ; Hulin, Cyrille ; Maloisel, Frédéric ; Macro, Margaret ; Karlin, Lionel ; Barué, Vanessa ; Chouaid, Christos ; Zerazhi, Hacène ; Leleu, Xavier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c942-5a214eeee9c626c9d5b5dc53b052eecde0011ff9f5c8743d59da0fad9ba6fff23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vincent, Laure</creatorcontrib><creatorcontrib>Charvet-Rumpler, Anne</creatorcontrib><creatorcontrib>Benboubker, Lotfi</creatorcontrib><creatorcontrib>Calmettes, Claire</creatorcontrib><creatorcontrib>Stoppa, Anne-Marie</creatorcontrib><creatorcontrib>Laribi, Kamel</creatorcontrib><creatorcontrib>Clement Filliatre, Lauriane</creatorcontrib><creatorcontrib>Honeyman, Fressia</creatorcontrib><creatorcontrib>Valentine, Richez</creatorcontrib><creatorcontrib>Hulin, Cyrille</creatorcontrib><creatorcontrib>Maloisel, Frédéric</creatorcontrib><creatorcontrib>Macro, Margaret</creatorcontrib><creatorcontrib>Karlin, Lionel</creatorcontrib><creatorcontrib>Barué, Vanessa</creatorcontrib><creatorcontrib>Chouaid, Christos</creatorcontrib><creatorcontrib>Zerazhi, Hacène</creatorcontrib><creatorcontrib>Leleu, Xavier</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vincent, Laure</au><au>Charvet-Rumpler, Anne</au><au>Benboubker, Lotfi</au><au>Calmettes, Claire</au><au>Stoppa, Anne-Marie</au><au>Laribi, Kamel</au><au>Clement Filliatre, Lauriane</au><au>Honeyman, Fressia</au><au>Valentine, Richez</au><au>Hulin, Cyrille</au><au>Maloisel, Frédéric</au><au>Macro, Margaret</au><au>Karlin, Lionel</au><au>Barué, Vanessa</au><au>Chouaid, Christos</au><au>Zerazhi, Hacène</au><au>Leleu, Xavier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effectiveness and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma in a Real-Life Population in France: The Remix Study</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>4312</spage><epage>4314</epage><pages>4312-4314</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-157942</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-4971 |
ispartof | Blood, 2022-11, Vol.140 (Supplement 1), p.4312-4314 |
issn | 0006-4971 1528-0020 |
language | eng |
recordid | cdi_crossref_primary_10_1182_blood_2022_157942 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
title | Effectiveness and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma in a Real-Life Population in France: The Remix Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T12%3A08%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effectiveness%20and%20Safety%20of%20Ixazomib%20in%20Combination%20with%20Lenalidomide%20and%20Dexamethasone%20in%20Relapsed%20or%20Refractory%20Multiple%20Myeloma%20in%20a%20Real-Life%20Population%20in%20France:%20The%20Remix%20Study&rft.jtitle=Blood&rft.au=Vincent,%20Laure&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=4312&rft.epage=4314&rft.pages=4312-4314&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-157942&rft_dat=%3Celsevier_cross%3ES0006497122034309%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122034309&rfr_iscdi=true |